Tisch

Boardwalk Names Scott Hallam President and CEO

Retrieved on: 
Monday, March 18, 2024
Tisch, Williams Companies, Boardwalk Pipelines, Culture, Growth, Greater Houston, Trustee, Commercial, United Way, Boardwalk, LP, Management

Scott Hallam, currently President and Chief Operating Officer, will succeed Stan as CEO and join Boardwalk's Board of Directors.

Key Points: 
  • Scott Hallam, currently President and Chief Operating Officer, will succeed Stan as CEO and join Boardwalk's Board of Directors.
  • Scott joined Boardwalk in September of 2023, bringing with him over two decades of upstream, midstream, and downstream experience in the natural gas industry.
  • "We thank Stan for his extraordinary leadership over the past 13 years," said Jim Tisch, President and CEO of Loews.
  • We are excited to work with Scott and are confident that Boardwalk will continue to excel under his leadership."

NYU Tisch & Yellowbrick Introduce "Business of Entertainment" -- Empowering Entertainment Industry Professionals

Retrieved on: 
Thursday, August 24, 2023
Ticketmaster, Learning, MTV, Partnership, Specialization, The arts, Apple TV, New York University Tisch School of the Arts, HBO, Sony Music, Curriculum, NYU, Business, Television, AMC, Associate, Tisch, Live Performance, Creativity, Activision Blizzard, Film, Student, Independent Film & Television Alliance, AMC Networks, Faculty, Growth, Netflix, Warner Music Group, Entertainment, Industrial design, Satellite emergency notification device, Amazon, Universal

NEW YORK, Aug. 24, 2023 /PRNewswire-PRWeb/ -- New York University's Tisch School of the Arts, in partnership with Yellowbrick, is thrilled to announce the highly-anticipated launch of "NYU Tisch Business of Entertainment," an immersive online course designed to equip creators, producers, and business professionals in the entertainment industry with the essential knowledge and skills to succeed in today's dynamic landscape.

Key Points: 
  • NYU Tisch School of the Arts and Yellowbrick launch "NYU Tisch Business of Entertainment," an immersive online course catering to creators, producers, and industry professionals, offering specialized tracks, comprehensive insights, and real-world expertise from major entertainment brands, aiming to equip participants with essential business knowledge and skills for success in the entertainment industry.
  • Building on the longstanding collaboration between Yellowbrick and NYU Tisch, this groundbreaking course caters to a diverse audience, offering a comprehensive understanding of the entertainment industry's inner workings.
  • "This course will empower a diverse range of individuals, from aspiring creators and producers to working business professionals in the entertainment industry."
  • Participants who successfully complete the NYU Tisch Business of Entertainment course will receive an official certificate of completion from NYU Tisch School of the Arts, further bolstering their credentials in the competitive entertainment industry.

LOTTERY COURIER SERVICE JACKPOT.COM LAUNCHES IN NEW YORK TO ALLOW NEW YORKERS TO ORDER OFFICIAL STATE LOTTERY TICKETS FROM THEIR PHONES

Retrieved on: 
Tuesday, August 1, 2023
Partnership, Marketing, Powerball, Empire State, ICAP, Certification, Gambling, New Yorker, Subway Series, Investment, National Council, National Council on Problem Gambling (United States), Sport, Mega Millions, Yankee Global Enterprises, Safety, New York Yankees, Tisch, New York Lottery

NEW YORK, Aug. 1, 2023 /PRNewswire/ -- Today, Jackpot.com, the online platform that allows lottery players to securely order official state lottery tickets from their mobile phone, tablet, or desktop launched in New York.  

Key Points: 
  • Jackpot.com allows New Yorkers to order tickets for Powerball, Mega Millions, Cash4Life, New York Lotto and Pick 10.
  • "Jackpot.com is happy to help New Yorkers order official state lottery tickets online with increased safety, security and convenience.
  • "The Jackpot.com platform has an innovative design and provides users an easily accessible interface to order official lottery tickets.
  • We are thrilled to be part of Jackpot.com's expansion in New York and its mission to positively change the way New Yorkers order official state lottery tickets, " said Carolyn Tisch.

Cvent and NYU School of Professional Studies Jonathan M. Tisch Center of Hospitality Join Forces to Foster Experiential Learning for Event Management Students

Retrieved on: 
Monday, June 5, 2023
Technology, Marketing, Training, Communications, Entertainment, Other Professional Services, Other Education, Continuing, University, Education, Consulting, Lodging, Professional Services, Destinations, Search Engine Marketing, Travel, Digital Marketing, Content Marketing, Other Technology, Software, Other Entertainment, Other Communications, Events, Concerts, Public Relations, Investor Relations, Partnership, NYU, Travel + Leisure, Tisch, Organization, Student, Amadeus, Certification, SPS, Conference, Nursing, Cvent

Cvent, an industry-leading meetings, events, and hospitality technology provider, is proud to collaborate with the NYU School of Professional Studies (NYU SPS) Jonathan M. Tisch Center of Hospitality.

Key Points: 
  • Cvent, an industry-leading meetings, events, and hospitality technology provider, is proud to collaborate with the NYU School of Professional Studies (NYU SPS) Jonathan M. Tisch Center of Hospitality.
  • The partnership will provide NYU SPS students with access to Cvent's comprehensive event marketing and management platform, including attendee engagement tools and marketing solutions.
  • The initiative between Cvent and NYU SPS's Jonathan M. Tisch Center is a testament to the importance of continuing education and collaboration between industry leaders and academic institutions.
  • By working together, both organizations aim to elevate the next generation of event management professionals and drive the industry forward.

FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients

Retrieved on: 
Tuesday, April 25, 2023
FDA, General Health, Health, Injection, Grey, Disability, CCL2, Quality of life, Research, Biomarker, Cerebrospinal fluid, Walking, Dementia, Tisch, MS, MMP9, Patient, B cell, Phase, Inflammation, Pharmaceutical industry, Medical device

The Phase II trial showed improvements across multiple areas in progressive MS patients with significant disability.

Key Points: 
  • The Phase II trial showed improvements across multiple areas in progressive MS patients with significant disability.
  • Additionally, patients who received the stem cell treatments showed improved bladder function, with 69% of patients showing improved post-void residual volume.
  • “These findings are unprecedented in the realm of researching stem cells as a treatment pathway for progressive MS patients.
  • The Phase II trial began in 2018 and was a randomized, double-blind, placebo-controlled clinical study with 54 patients.

Two Renowned Cancer Experts to Head New Tisch Cancer Hospital at The Mount Sinai Hospital

Retrieved on: 
Thursday, March 16, 2023
National Cancer Institute (Egypt), Research, Cancer, Health, Nephrology, Nursing, MD, Hospital, Trustee, Bangladesh Technical Education Board, Department of Defense Serum Repository, Medicine, Mount Sinai Hospital (Manhattan), School, Mount Sinai Health System, Principal investigator, Surgeon, Prostate cancer, Informatics, Icahn School of Medicine at Mount Sinai, Social justice, Patient, Sinai Health System, Interference microscopy, Madison Avenue, National Cancer Institute, Medical director, American Cancer Society, Master of Surgery, Faculty, MBBS, Surgical oncology, Cardiology, Knowledge, Health system, Doctor of Philosophy, Geriatrics, Lead, News, Artificial intelligence, Dentistry, Tisch, Urology

NEW YORK, March 16, 2023 /PRNewswire-PRWeb/ -- Two top cancer experts have been named to lead Mount Sinai's new Tisch Cancer Hospital, which is under development and due to open in 2027. Cardinale B. Smith, MD, PhD, has been appointed Chief Medical Officer for the Tisch Cancer Hospital and Vice President of Cancer Clinical Affairs, and Ash Tewari, MBBS, MCh, has been appointed Surgeon-in-Chief of the Tisch Cancer Hospital.

Key Points: 
  • Cardinale B. Smith, MD, PhD, has been appointed Chief Medical Officer for the Tisch Cancer Hospital and Vice President of Cancer Clinical Affairs, and Ash Tewari, MBBS, MCh, has been appointed Surgeon-in-Chief of the Tisch Cancer Hospital.
  • The Tisch Cancer Hospital will be a state-of-the-art cancer facility at The Mount Sinai Hospital, thanks to a generous $60 million gift from James S. and Merryl H. Tisch.
  • "Mount Sinai's vision for the Tisch Cancer Hospital was bold," said Mr. Tisch, Co-Chairman of the Boards of Trustees of the Mount Sinai Health System.
  • "The Tisch Cancer Hospital will be a hospital within the hospital that is supported by experts from various areas of medicine," Dr. Tewari said.

New Study Reveals New Potential Therapeutic Target for Experimental Multiple Sclerosis Treatment

Retrieved on: 
Tuesday, March 7, 2023
Health, Stem Cells, Neurology, Other Health, Clinical Trials, Research, Science, MS, HIV disease progression rates, Patient, Microglia, Tisch, Multiple sclerosis, TGF, Regenerative medicine, Brain, Bone marrow, Cell, Pharmaceutical industry

The Tisch MS Research Center of New York (MSRCNY), the world’s largest independent research center focused on multiple sclerosis, has published new research finding that microglia could be a potential therapeutic target for mesenchymal stem cell-derived neural progenitor cell (MSC-NP) therapy, an experimental approach to treating multiple sclerosis.

Key Points: 
  • The Tisch MS Research Center of New York (MSRCNY), the world’s largest independent research center focused on multiple sclerosis, has published new research finding that microglia could be a potential therapeutic target for mesenchymal stem cell-derived neural progenitor cell (MSC-NP) therapy, an experimental approach to treating multiple sclerosis.
  • This treatment approach uses bone marrow cells (MSC-NPs) that are injected into the spinal fluid of the patient, aiming to slow or reverse neurological disability in patients with MS.
  • The Tisch Center's study focused on the potential of microglia, which are innate immune cells in the brain known to contribute to the disease progression of MS, as a therapeutic target for MS.
  • As a result, the research concluded that MSC-NPs could promote beneficial microglial polarization through these secreted factors.

Researchers Create Novel Human Brain Model to Understand and Replicate Stem Cell Dysregulation in Multiple Sclerosis

Retrieved on: 
Wednesday, February 8, 2023
Research, Neurology, Genetics, Stem Cells, Biotechnology, Health, Pharmaceutical, General Health, Science, B cell, Organoid, RRMS, PPMS, Multiple sclerosis, Neuron, SPMS, Maintenance, Patient, Epistasis, Cell, Cell cycle, Tisch, Immune system, MS, Pharmaceutical industry, Vaccine, Biology Open

These organoids contain the patient’s genetic information allowing researchers, for the first time ever, to analyze the role of an individual’s genetic background in MS in a new non-immune-based human model.

Key Points: 
  • These organoids contain the patient’s genetic information allowing researchers, for the first time ever, to analyze the role of an individual’s genetic background in MS in a new non-immune-based human model.
  • Recently published in Biology Open, the study revealed novel insights into MS cellular dysregulation and found that a patient’s genetic background can directly alter stem cell function and result in differences in the development of myelin-producing oligodendrocyte cells.
  • Until now, the relative inaccessibility of human brain tissues has been a significant barrier to advancing research into the origin and evolution of MS.
  • Within these models, researchers observed dysregulation of the neural progenitor proliferation and differentiation capacity, leading to increased neuronal differentiation and decreased glial cell development.

Primary Progressive MS Is Confirmed To Be Distinct From Other MS Subtypes

Retrieved on: 
Monday, February 6, 2023
Health, Neurology, Other Health, Clinical Trials, Research, Science, RRMS, Spinal cord, PPMS, Immunoglobulin G, Patient, CSF, Tisch, Pathology, Cerebrospinal fluid, Antibody, Disease, Multiple sclerosis, Filtration, Disability studies, MS, Remyelination, Vaccine, Brain

The Tisch MS Research Center of New York, the world’s largest independent research center focused on multiple sclerosis, has published groundbreaking new research classifying primary progressive multiple sclerosis (PPMS) as pathophysiologically distinct from other forms of MS.

Key Points: 
  • The Tisch MS Research Center of New York, the world’s largest independent research center focused on multiple sclerosis, has published groundbreaking new research classifying primary progressive multiple sclerosis (PPMS) as pathophysiologically distinct from other forms of MS.
  • Published in the journal Brain, the study finally confirms a conclusion long suspected by the scientific community: PPMS is an antibody-mediated disease with unique clinical and pathological features.
  • Tisch MSRCNY researchers developed the first ever animal model of PPMS via intrathecal injection of cerebrospinal fluid (CSF) from PPMS patients into the cervical spinal cord.
  • Unlike the CSF from patients with other forms of MS (relapsing-remitting MS (RRMS) and secondary progressive MS), only PPMS patient CSF induced motor disability and hallmark MS-like pathology in the spinal cord including: demyelination, impaired remyelination, reactive astrogliosis, and axonal damage.

Online Lottery Ticket Platform Jackpot.com Launches in Texas With $42 Million in Funding

Retrieved on: 
Monday, January 9, 2023
Sports, Casino, Gaming, General Entertainment, Entertainment, General Sports, Aurum, Radio, National Council, Texas Lottery, Business operations, Name, Cleveland Cavaliers, Entertainment, StubHub, Lotto, Certification, NBA, Safety, Rocket, Internet, Dallas, Partnership, Houston Rockets, Sport, Marketing, ID, Dallas Cowboys, National Council on Problem Gambling (United States), Powerball, San Francisco Giants, Gambling, Coffee, Lone Star, Multimedia, Mega Millions, Investment, New York Giants, New York Yankees, Tisch

Jackpot.com, the online lottery ticket platform, launched today in Texas with $42M in funding from some of the country’s top professional sports franchises and marketing partnerships with the Dallas Cowboys, Houston Rockets, and San Antonio Spurs.

Key Points: 
  • Jackpot.com, the online lottery ticket platform, launched today in Texas with $42M in funding from some of the country’s top professional sports franchises and marketing partnerships with the Dallas Cowboys, Houston Rockets, and San Antonio Spurs.
  • Texans can instantly play the Powerball, Mega Millions, Lotto Texas, and Texas Two Step, then view scanned copies of their purchased tickets in their account.
  • The Texas Lottery is the third largest in the US, generating more than $8 billion in record-breaking sales in the 2022 fiscal year, according to the Texas Lottery Commission .
  • Over the last 30 years, the Texas Lottery has contributed over $35 billion to supporting public education in Texas.